188 related articles for article (PubMed ID: 7549499)
1. Mucosal histamine content and histamine secretion in Crohn's disease, ulcerative colitis and allergic enteropathy.
Raithel M; Matek M; Baenkler HW; Jorde W; Hahn EG
Int Arch Allergy Immunol; 1995 Oct; 108(2):127-33. PubMed ID: 7549499
[TBL] [Abstract][Full Text] [Related]
2. Biopsy histamine in ulcerative colitis and Crohn's disease.
Baenkler HW; Lux G; Günthner R; Kohlhäufl M; Matek W
Hepatogastroenterology; 1987 Dec; 34(6):289-90. PubMed ID: 3428863
[TBL] [Abstract][Full Text] [Related]
3. Colonic mucosal interleukin-6 in inflammatory bowel disease.
Mitsuyama K; Sasaki E; Toyonaga A; Ikeda H; Tsuruta O; Irie A; Arima N; Oriishi T; Harada K; Fujisaki K
Digestion; 1991; 50(2):104-11. PubMed ID: 1804734
[TBL] [Abstract][Full Text] [Related]
4. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
5. Mucosal metabolism in ulcerative colitis and Crohn's disease.
Duffy MM; Regan MC; Ravichandran P; O'Keane C; Harrington MG; Fitzpatrick JM; O'Connell PR
Dis Colon Rectum; 1998 Nov; 41(11):1399-405. PubMed ID: 9823806
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
7. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
[TBL] [Abstract][Full Text] [Related]
8. Abnormal leukotriene C4 released by unaffected jejunal mucosa in patients with inactive Crohn's disease.
Casellas F; Guarner F; Antolín M; Rodríguez R; Salas A; Malagelada JR
Gut; 1994 Apr; 35(4):517-22. PubMed ID: 8174991
[TBL] [Abstract][Full Text] [Related]
9. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease.
Kimura H; Miura S; Shigematsu T; Ohkubo N; Tsuzuki Y; Kurose I; Higuchi H; Akiba Y; Hokari R; Hirokawa M; Serizawa H; Ishii H
Dig Dis Sci; 1997 May; 42(5):1047-54. PubMed ID: 9149061
[TBL] [Abstract][Full Text] [Related]
10. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.
Rachmilewitz D; Stamler JS; Bachwich D; Karmeli F; Ackerman Z; Podolsky DK
Gut; 1995 May; 36(5):718-23. PubMed ID: 7541008
[TBL] [Abstract][Full Text] [Related]
11. Keratinocyte growth factor in inflammatory bowel disease. Increased mRNA transcripts in ulcerative colitis compared with Crohn's disease in biopsies and isolated mucosal myofibroblasts.
Bajaj-Elliott M; Breese E; Poulsom R; Fairclough PD; MacDonald TT
Am J Pathol; 1997 Nov; 151(5):1469-76. PubMed ID: 9358773
[TBL] [Abstract][Full Text] [Related]
12. Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.
Minami T; Tojo H; Shinomura Y; Matsuzawa Y; Okamoto M
Gut; 1994 Nov; 35(11):1593-8. PubMed ID: 7828979
[TBL] [Abstract][Full Text] [Related]
13. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases.
Koch TR; Carney JA; Go VL
Dig Dis Sci; 1987 Apr; 32(4):369-76. PubMed ID: 2435473
[TBL] [Abstract][Full Text] [Related]
14. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease.
Bernstein CN; Robert ME; Eysselein VE
Am J Gastroenterol; 1993 Jun; 88(6):908-13. PubMed ID: 7684884
[TBL] [Abstract][Full Text] [Related]
15. Intestinal mast cell responses in idiopathic inflammatory bowel disease. Histamine release from human intestinal mast cells in response to gut epithelial proteins.
Fox CC; Lichtenstein LM; Roche JK
Dig Dis Sci; 1993 Jun; 38(6):1105-12. PubMed ID: 7685262
[TBL] [Abstract][Full Text] [Related]
16. Mast cell mediated ion transport in intestine from patients with and without inflammatory bowel disease.
Crowe SE; Luthra GK; Perdue MH
Gut; 1997 Dec; 41(6):785-92. PubMed ID: 9462211
[TBL] [Abstract][Full Text] [Related]
17. Increased colonic mucosal angiotensin I and II concentrations in Crohn's colitis.
Jaszewski R; Tolia V; Ehrinpreis MN; Bodzin JH; Peleman RR; Korlipara R; Weinstock JV
Gastroenterology; 1990 Jun; 98(6):1543-8. PubMed ID: 2159930
[TBL] [Abstract][Full Text] [Related]
18. High endothelin-1 immunoreactivity in Crohn's disease and ulcerative colitis.
Murch SH; Braegger CP; Sessa WC; MacDonald TT
Lancet; 1992 Feb; 339(8790):381-5. PubMed ID: 1346658
[TBL] [Abstract][Full Text] [Related]
19. Histamine release from gut mast cells from patients with inflammatory bowel diseases.
Nolte H; Spjeldnaes N; Kruse A; Windelborg B
Gut; 1990 Jul; 31(7):791-4. PubMed ID: 1695160
[TBL] [Abstract][Full Text] [Related]
20. Effect of substance P on histamine secretion from gut mucosa in inflammatory bowel disease.
Raithel M; Schneider HT; Hahn EG
Scand J Gastroenterol; 1999 May; 34(5):496-503. PubMed ID: 10423066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
